Company Description
For Enzo Biochem, antisense is perfectly sensible. The biotech company's Enzo Therapeutics subsidiary is developing antisense technology, a kind of...
Key Enzo Biochem Financials
| Company Type | Public - NYSE: ENZ Main Headquarters |
|---|---|
| Fiscal Year-End | July |
| 2007 Sales (mil.) | $52.9 |
| 2007 Employees | 454 |
More Enzo Biochem Financials (10 pages)
Rankings
- S&P 600
Competition
Competitive Landscape for Healthcare
Although a large majority of hospitals are operated by nonprofits, most doctor offices, nursing homes, insurers, and manufacturers of medical products are for-profit entities. The industry is one of...
Read more about Enzo Biochem's competition across multiple industries
Top Enzo Biochem Competitors
Sponsored Links
The Business Directory
Enzo Biochem Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman and CEO | Elazar Rabbani | Network | E-mail |
| President, CFO, and Director | Barry W. Weiner | Network | E-mail |
| COO, Secretary, Treasurer, and Director | Shahram K. Rabbani | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Enzo Biochem News
Sponsored Opportunity
